Compare

Amdocs/$DOX

1D1W1M3M6MYTD1Y5YMAX

About Amdocs

Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
Ticker
$DOX
Sector
Business services
Primary listing
NASDAQ
Employees
26,969

Amdocs Metrics

BasicAdvanced
$6.3B
14.45
$4.20
0.42
$2.19
3.75%

What the Analysts think about Amdocs

Analyst ratings (Buy, Hold, Sell) for Amdocs stock.
Analyst projections of the future price of Amdocs stock.

Bulls say / Bears say

Amdocs has secured a 10-year agreement with VEON to run and modernise its core technology operations across Eurasia, adding a long-duration customer relationship and expanding its regional reach. (VEON)
Amdocs said its aOS platform won 10 customer engagements within five months of launch, with early initiatives at operators including Verizon and TELUS. That is early evidence of demand for its AI-led telco offering, although the scale of the engagements varies. (The Motley Fool)
Managed services reached a record 67% of quarterly revenue, while the 12-month backlog rose 2.7% year on year to $4.26 billion. This recurring work and backlog provide revenue visibility, and the non-GAAP operating margin also improved by 20 basis points. (The Motley Fool)
Underlying growth remains modest: Amdocs forecast fiscal 2026 revenue growth of 2.6%–3.4% in constant currency, and Q3 revenue rose just 2.2% on that basis. Management expects about half of the year's growth to come from acquisitions. (Nasdaq)
A $106 million restructuring charge sharply reduced reported profitability: Q3 GAAP diluted EPS fell to $0.59 from $1.39 a year earlier. Amdocs now expects full-year GAAP EPS to decline 3%–5%, rather than grow 12%–15% as previously forecast. (Nasdaq)
The agentic-AI growth case depends on customers moving beyond trials: management said adoption speed will depend on how aggressively operators pursue the technology. It also flagged future AI technology and token costs as unknown, which could delay returns or pressure margins. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 14 Oct 2026.

Amdocs Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Amdocs Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Amdocs

AllEURUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.